MAP9 loss triggers chromosomal instability, initiates colorectal tumorigenesis and is associated with poor survival of colorectal cancer patients.
Chromosomal instability (CIN) is a common phenomenon in colorectal cancer (CRC), but its role and underlying cause remain unknown. We have identified that mitotic regulator microtubule-associated protein 9 (MAP9) as a critical regulator of CIN in CRC. We thus studied the effect of MAP9 loss on CRC in Map9 knockout mice and in cell lines. We generated colon epithelial-specific Map9 knockout mice and evaluated CRC development. Effect of Map9 knockout on CRC progression was determined in chemical or ApcMin/+-induced CRC. Molecular mechanism of MAP9 was determined using spectral karyotyping (SKY), microtubule assays and whole genome sequencing (WGS). Clinical significance of MAP9 was examined in 141 CRC patients. Spontaneous colonic tumors (9.1%) were developed in colon epithelium-specific Map9 knockout mice at 17 months, but none was observed in wildtype littermates. Map9 deletion accelerated CRC formation both in ApcMin/+ mice and azoxymethane-treated mice, and reduced survival in ApcMin/+ mice. Mechanistically, MAP9 stabilized microtubules and mediated mitotic spindle assembly. MAP9 also maintained the spindle pole integrity and protected K-fibre from depolymerization at spindle poles. MAP9 loss induced severe mitosis failure, chromosome segregation errors and aneuploidy, leading to transformation of normal colon epithelial cells. WGS confirmed enhanced CIN in intestinal tumors from Map9 knockout ApcMin/+ mice. In CRC patients, MAP9 was frequently silenced and its down-regulation was associated with poor survival. MAP9 is a microtubule stabilizer that contributes to spindle stability and inhibits colorectal tumorigenesis, supporting the role of MAP9 as a tumor suppressor for preventing CIN in CRC.